|Articles|July 31, 2018

Blockchain Helps Patients in National Hepatitis Elimination Program

External Link - Rymedi Mongolia Press Release.pdf

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

SCOPE Summit 2026: How Payment Practices and Operational Burden Are Changing Site Behavior

ByHolly Leslie,Andy Studna, Senior Editor

February 10th 2026

Evinova, Bristol Myers Squibb Partner to Apply AI to Global Clinical Development

ByAndy Studna, Senior Editor

February 10th 2026

ACT Brief: Purpose Meets Operational Focus, Acceleration Shifts Upstream, and AI Delivers Near-Term Impact

ByAndy Studna, Senior Editor

February 10th 2026

SCOPE Summit 2026: Making ESG a Core Measure of Clinical Research Quality

ByOtis Johnson, PhD, MPA,Andy Studna, Senior Editor

February 9th 2026

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist approved as Ozempic for type 2 diabetes and as Wegovy for weight management, has demonstrated robust and clinically meaningful weight loss in randomized controlled trials, as well as in real-world evidence settings. Credit: Stock.Adobe.com/Tobias Arhelger.

Interdependence-Aware Attribution in Real-World Evidence: A Case Study on Semaglutide Weight Loss Outcomes

ByEytan Ellenberg, MD, MPH, PhD,Eldad Katorza, MD, MSC, MBA

February 9th 2026

Blockchain Helps Patients in National Hepatitis Elimination Program

Newsletter

Related Content

SCOPE Summit 2026: How Payment Practices and Operational Burden Are Changing Site Behavior

Evinova, Bristol Myers Squibb Partner to Apply AI to Global Clinical Development

ACT Brief: Purpose Meets Operational Focus, Acceleration Shifts Upstream, and AI Delivers Near-Term Impact

SCOPE Summit 2026: Making ESG a Core Measure of Clinical Research Quality

Interdependence-Aware Attribution in Real-World Evidence: A Case Study on Semaglutide Weight Loss Outcomes

Trending on Applied Clinical Trials Online

Evinova, Bristol Myers Squibb Partner to Apply AI to Global Clinical Development

SCOPE Summit 2026: How Sponsors Are Prioritizing AI Adoption Across Clinical Trials

SCOPE Summit 2026: Reducing Patient Burden Is the Foundation of Wearable Success in Oncology

Interdependence-Aware Attribution in Real-World Evidence: A Case Study on Semaglutide Weight Loss Outcomes

ACT Brief: Purpose Meets Operational Focus, Acceleration Shifts Upstream, and AI Delivers Near-Term Impact